YAP1 and cutaneous melanoma: It then promotes the phosphorylation of YAP and reduces its nuclear translocation, eventually inhibiting its nuclear enrichment to lead to the activation of the Hippo signaling pathway, which slows the pathogenesis of skin melanoma.